The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of HLA class I expression on the tumor immune microenvironment and prognosis in prostate cancer.
 
Pornlada Likasitwatanakul
No Relationships to Disclose
 
Carissa Besonen
No Relationships to Disclose
 
Negar Sadeghipour
Employment - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Sharon Wu
Employment - Caris Life Sciences
Research Funding - Caris Life Sciences
 
Andrew Elliott
Employment - Caris Life Sciences
 
Ali Arafa
No Relationships to Disclose
 
Akash Patnaik
Stock and Other Ownership Interests - Gilead Sciences; Infinity Pharmaceuticals; Merck; Merck
Honoraria - BostonGene; Medscape; Prime Oncology
Consulting or Advisory Role - Curio Science; Exelixis; Gerson Lehrman Group; Guidepoint Pharmacy
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Laekna Health Care (Inst); Progenics (Inst); Xencor (Inst); Zenith Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Exelixis; Prime Oncology
 
Vivek Narayan
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Janssen Oncology; Merck; Myovant Sciences; Pfizer/Astellas; Regeneron; Sanofi; Terns Pharmaceuticals; Xencor
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - US Patent No. 18/708,529
Travel, Accommodations, Expenses - Eisai; Exelixis; Pfizer
 
Alexander Tsai
No Relationships to Disclose
 
Laura Sena
Research Funding - Panbela Therapeutics (Inst)
 
Nicholas Zorko
Consulting or Advisory Role - Bayer; Dendreon; Takeda (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences; Telix Pharmaceuticals
 
Justin Hwang
Consulting or Advisory Role - Astrin Bio; Tempus
Research Funding - Astrin Biosciences
 
Emmanuel Antonarakis
Consulting or Advisory Role - AADi; AIkido Pharma; Amgen; AstraZeneca; Bayer (Inst); Blue Earth Diagnostics; Corcept Therapeutics; Curium Pharma; Foundation Medicine; Hookipa Pharma; Janssen Biotech; Lilly; Menarini Silicon Biosystems; Merck; Pfizer; Sanofi; Tango Therapeutics; Tempus; Z-Alpha
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Merck (Inst); Orion Health (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen